Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

Production of Sputnik V abroad will be up to 6 mln doses a month from July

Via the Russian Direct Investment Fund, the authorities established a mechanism for using foreign sites, where the substance for the production of vaccines is sent to, the minister said.

Bharat Biotech’s vaccine Covaxin shows that it is 77.8% efficacy

The vaccine is produced with Bharat Biotech's in-house vero cell manufacturing platform that has the capacity to deliver about 300 million doses.

Sputnik V certain copes with the Indian strain, expert says

The Sputnik V vaccine remained highly effective. According to the expert, it protects 100% from severe forms of the disease and deaths.

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...

Positive results were obtained for the drug Zanubrutinib in a comparative trial with Isrutinib

Brukinsa® (zanubrutinib) is under regulatory review for relapsed, refractory MCL in the Russian Federation with potential approval at the end of the 2021.

COVID-19 pathogenetic treatment is approved as an additional indication for olokizumab

Approval for a new indication will help healthcare professionals make streamlined decisions to administer preemptive anticytokine therapy.
spot_img

Expert Articles

spot_img